MYCBP2 Antikörper (AA 60-100) (AbBy Fluor® 647)

Produktnummer ABIN1402356

Produktdetails anti-MYCBP2 Antikörper (AbBy Fluor® 647)

Target: MYCBP2 (MYC Binding Protein 2 (MYCBP2))

Bindungsspezifität: AA 60-100

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MYCBP2 Antikörper ist konjugiert mit AbBy Fluor® 647

Applikation: Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Kreuzreaktivität: Human, Maus, Ratte

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human MYCBP2

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu MYCBP2

Target: MYCBP2 (MYC Binding Protein 2 (MYCBP2))

Andere Bezeichnung: MYCBP2 (MYCBP2 Produkte)

Hintergrund:

Synonyms: Pam/highwire/rpm-1 protein, Phr1, MYC binding protein 2, PAM, Pam, highwire, rpm 1, Protein associated with Myc, Probable E3 ubiquitin-protein ligase MYCBP2, Myc-binding protein 2, Pam/highwire/rpm-1 protein, Protein associated with Myc, MYCB2_HUMAN.

Background: MYCBP2 belongs to the highwire family. It is a probable E3 ubiquitin-protein ligase which mediates ubiquitination and subsequent proteasomal degradation of target proteins. MYCBP2 may function as a facilitator or regulator of transcriptional activation by MYC and have a role during synaptogenesis. There are two different isoforms.

Gen-ID: 23077

UniProt: O75592

Pathways: SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion